Skip to main content

NovoLog FlexPen News

Related terms: FlexPen

FDA Clears New Insulin Pump and Algorithm-Based Software to Support Enhanced Automatic Insulin Delivery

May 19, 2023 – Today, the U.S. Food and Drug Administration cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with type 1 diabetes....

FDA Medwatch Alert: Caution When Using Pen Needles to Inject Medicines: FDA Safety Communication

Audience: Patients and caregivers who use or are considering using pen injectors with pen needles to inject prescription medicines. Health care providers who treat patients, or who train...

Novo Nordisk Receives FDA Approval for Fiasp (insulin aspart injection), a New Fast-Acting Mealtime Insulin

PLAINSBORO, N.J., Sept. 29, 2017 /PRNewswire/ – Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) approved Fiasp (insulin aspart injection) 100 Units/mL, a fast-acting...

FDA Medwatch Alert: NovoLog insulin aspart [rDNA origin] injection)

[Posted 09/14/2005] Novo Nordisk Incorporated and FDA notified pharmacists of an initiative implemented to help prevent dispensing errors. To facilitate the dispensing of the correct product, color...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Diabetes, Type 2, Diabetes, Type 1

NovoLog FlexPen patient information at Drugs.com